We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HOOD:NASDAQRobinhood Markets, Inc. Analysis

Data as of 2026-06-01 - not real-time

$90.73

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Robinhood (HOOD) is trading well above its short‑ and mid‑term moving averages while still lagging the long‑term average, indicating recent strength but a need for sustained upside to re‑align with its 200‑day trend. The RSI sits in the low‑to‑mid‑60s, suggesting solid momentum without being overbought, and the MACD remains bullish, reinforced by a rising volume trend. However, the DCF fair‑value estimate is substantially lower than the current market price, and a price‑to‑earnings multiple far exceeds both the industry average and the forward‑PE, flagging clear overvaluation. Recent news of the WonderFi acquisition and regulatory approvals for new brokerage services in Singapore and Canada provide a growth catalyst, expanding the platform’s geographic footprint and product suite. Despite these positives, the stock’s high beta, elevated 30‑day volatility, and historical drawdown depth amplify downside risk, especially in a sector sensitive to regulatory shifts. In summary, HOOD combines strong short‑term technical momentum and strategic expansion with a stretched valuation and pronounced risk profile, making the near‑term outlook cautiously optimistic but contingent on continued earnings growth and market sentiment.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and supportive RSI momentum
  • Increasing trading volume indicating heightened investor interest
  • Technical price above short‑term averages despite long‑term lag

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation premium relative to DCF and peers
  • Potential earnings uplift from WonderFi integration
  • Elevated beta and volatility that could temper price appreciation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic expansion into Canada and Singapore broadening addressable market
  • Strong operating margins and high ROE supporting sustainable profitability
  • Long‑term growth narrative outweighing current overvaluation if execution succeeds

Key Metrics & Analysis

Financial Health

Revenue Growth15.10%
Profit Margin41.12%
P/E Ratio44.0
ROE21.46%
ROA5.19%
Debt/Equity140.48
P/B Ratio8.8
Op. Cash Flow$3.0B
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI63.5
Support$73.18
Resistance$94.40
MA 20$78.82
MA 50$77.11
MA 200$103.82
MACDBullish
VolumeIncreasing
Fear & Greed Index92.77

Valuation

Fair Value$64.77
Target Price$98.77
Upside/Downside8.86%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.27
Volatility76.91%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.